Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AxiaMed is a healthcare payments technology company focused on secure patient payment infrastructure for providers, health systems, and healthcare software vendors. Rather than developing therapeutics, it operates a SaaS-based integrated payments platform, Payment Fusion, that connects into EHR, practice management, and revenue-cycle systems to support payment processing, gateways, settlements, reporting, and PCI-focused security. The company built its business around healthcare-specific payment workflows and interoperability across patients, providers, and payers. AxiaMed was acquired by Bank of America in April 2021, and its technology is now reflected in Bank of America’s Healthcare Payment Solutions offering through Axia Technologies, Inc., a wholly owned subsidiary of Bank of America, N.A.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AxiaMed.